^(131)I-SPECT/CT在分化型甲状腺癌诊治中的应用  

Clinical application of ^(131)I-SPECT/CT in the management of differentiated thyroid cancer

作　　者：沈晨天 薛艳丽[1] 邱忠领[1] 宋红俊[1] 魏伟军[1] 罗全勇[1] 

机构地区：[1]上海交通大学附属第六人民医院核医学科,上海200233

出　　处：《中国医学影像技术》2015年第7期1119-1123,共5页Chinese Journal of Medical Imaging Technology

摘　　要：131I-SPECT/CT融合显像技术整合功能影像学和解剖影像学于一体,可同时反映病灶的131I摄取功能和解剖结构信息,在分化型甲状腺癌(DTC)的诊治中具有重要作用。相对于全身平面131I扫描(131I-WBS)而言,131I-SPECT/CT在病灶的定性及定位诊断,肿瘤分期与危险性分层,对131I治疗剂量的估算等方面具有重要的临床价值。本文就131ISPECT/CT融合显像技术在DTC诊治中的应用进行综述。131I-SPECT/CT plays an important role in the management of differentiated thyroid cancer（DTC）patients,because it can allow accurate alignment of anatomical and functional images in an all-in-one procedure and show metabolic and anatomical information of a lesion.When compared with 131I-WBS,131I-SPECT/CT may provide a more important contribution to the identification and localization of radioiodine uptake sites,staging and risk stratification,clinical management as well as highly accurate dosimetry-based 131 I treatment in patients with DTC.The clinical value of 131I-SPECT/CT in the management of differentiated thyroid cancer was reviewed in this paper.

关 键 词：体层摄影术 发射型计算机 单光子 甲状腺肿瘤 分化型甲状腺癌 危险性分层 

分 类 号：R817[医药卫生—影像医学与核医学] R736.1[医药卫生—放射医学]